JP2002508338A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002508338A5 JP2002508338A5 JP2000538720A JP2000538720A JP2002508338A5 JP 2002508338 A5 JP2002508338 A5 JP 2002508338A5 JP 2000538720 A JP2000538720 A JP 2000538720A JP 2000538720 A JP2000538720 A JP 2000538720A JP 2002508338 A5 JP2002508338 A5 JP 2002508338A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- hiv
- composition according
- lentivirus
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6957997P | 1997-12-12 | 1997-12-12 | |
| US60/069,579 | 1997-12-12 | ||
| PCT/US1998/025720 WO1999030742A1 (en) | 1997-12-12 | 1998-12-11 | Therapeutic use of lentiviral vectors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002508338A JP2002508338A (ja) | 2002-03-19 |
| JP2002508338A5 true JP2002508338A5 (cg-RX-API-DMAC7.html) | 2006-01-26 |
Family
ID=22089926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000538720A Pending JP2002508338A (ja) | 1997-12-12 | 1998-12-11 | レンチウィルスベクターの治療使用 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1037669A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002508338A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20010033062A (cg-RX-API-DMAC7.html) |
| AU (1) | AU749059B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2314683A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999030742A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2388301C (en) | 1999-10-22 | 2011-01-04 | Aventis Pasteur Limited | Modified gp100 and uses thereof |
| US6656706B2 (en) | 1999-12-23 | 2003-12-02 | The United States Of America As Represented By The Department Of Health And Human Services | Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes |
| US7851212B2 (en) | 2000-05-10 | 2010-12-14 | Sanofi Pasteur Limited | Immunogenic polypeptides encoded by MAGE minigenes and uses thereof |
| US6712612B1 (en) | 2000-12-12 | 2004-03-30 | Genecure Llc | Safe and stable retroviral helper cell line and related compositions and methods |
| WO2004060346A2 (en) | 2002-12-30 | 2004-07-22 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
| WO2004094642A2 (en) | 2003-04-24 | 2004-11-04 | Fondazione Centro San Raffaele Del Monte Tabor | Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof |
| WO2009049350A1 (en) | 2007-10-15 | 2009-04-23 | The University Of Queensland | Expression system for modulating an immune response |
| US9795658B2 (en) | 2010-04-20 | 2017-10-24 | Admedus Vaccines Pty Ltd | Expression system for modulating an immune response |
| CN108601951B (zh) | 2015-12-09 | 2022-11-22 | 金港医疗(澳大利亚)私人有限公司 | 用于治疗的免疫调节组合物 |
| US11285191B2 (en) | 2016-07-26 | 2022-03-29 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Immunostimulatory compositions and uses therefor |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0816507A4 (en) * | 1995-03-16 | 1998-07-01 | Hisamitsu Pharmaceutical Co | NEW RECOMBINANT GEN |
| US5650309A (en) * | 1995-05-16 | 1997-07-22 | The Regents Of The University Of California | Viral vectors |
| US6013516A (en) * | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| WO1997020052A1 (en) * | 1995-11-28 | 1997-06-05 | Clinical Technologies, Inc. | Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome |
| ATE455858T1 (de) * | 1995-11-28 | 2010-02-15 | Univ Johns Hopkins Med | Konditionell replizierende virale vektoren und ihre verwendung |
| AP964A (en) * | 1996-02-21 | 2001-05-11 | Julianna Lisziewicz | Methods and compositions for protective and therapeutic genetic immunisation. |
| CA2247091A1 (en) * | 1996-03-05 | 1997-09-12 | The Regents Of The University Of California | Recombinant live feline immunodeficiency virus and proviral dna vaccines |
| WO1998003669A2 (en) * | 1996-07-22 | 1998-01-29 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Vectors for inhibiting hiv and tumor growth |
| JP2001513643A (ja) * | 1997-03-06 | 2001-09-04 | ウーベルラ、クラウス | レンチウイルスをベースとするベクター及びベクター系 |
| GB9704977D0 (en) * | 1997-03-11 | 1997-04-30 | Univ Glasgow | FIV vaccine |
| EP1003894A2 (en) * | 1997-07-18 | 2000-05-31 | Chiron Corporation | Lentiviral vectors |
-
1998
- 1998-12-11 JP JP2000538720A patent/JP2002508338A/ja active Pending
- 1998-12-11 WO PCT/US1998/025720 patent/WO1999030742A1/en not_active Ceased
- 1998-12-11 KR KR1020007006423A patent/KR20010033062A/ko not_active Withdrawn
- 1998-12-11 EP EP98962895A patent/EP1037669A4/en not_active Withdrawn
- 1998-12-11 CA CA002314683A patent/CA2314683A1/en not_active Abandoned
- 1998-12-11 AU AU18035/99A patent/AU749059B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2267452B8 (en) | A soluble complex comprising a retroviral surface glycoprotein | |
| WO1990015066A3 (fr) | Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus | |
| WO2001010456A3 (en) | Peptides that block viral infectivity and methods of use thereof | |
| TR200001553T2 (tr) | HIV-1 Tat veya bunun türevleri. | |
| ES2113854T3 (es) | Derivados de albumina con funciones terapeuticas. | |
| DE69632256D1 (de) | Antivirale proteine, dafür kodierende dna, und deren verwendung | |
| MXPA02007478A (es) | Vacuna contra el virus de inmunodeficiencia humana. | |
| AU3485800A (en) | Inhibitors of aspartyl protease | |
| RU96116005A (ru) | Штамм hominis immunodeficiti virus (hiv-i) вич-i/россия/гм-12-95 (ru1295) субтипа в для диагностических и вакцинных препаратов | |
| WO2000061067A3 (fr) | Vaccin anti-vih-1 comprenant tout ou partie de la proteine tat de vih-1 | |
| NO940810L (no) | Behandling av virusinfeksjoner | |
| CA2195125A1 (en) | Difluorostatone antiviral agents | |
| BG101175A (bg) | Тройна анти-нiv комбинация | |
| JP2002523426A5 (cg-RX-API-DMAC7.html) | ||
| ATE509942T1 (de) | Nichtproteolysierbare oligopeptide, die das glycoprotein gp41 von hiv inhibieren | |
| EP1690545A3 (en) | Preparation of Product R and product so obtained | |
| FI881123L (fi) | Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar. | |
| DE69922642D1 (de) | Virale chimären aus caev und hiv-1 genetischen elementen | |
| WO2002034909A3 (en) | Engineered chimera of hiv protein fragments and uses thereof | |
| RU2003125554A (ru) | Природные антитела, активные против вируса иммунодефицита человека (вич) | |
| WO2004041194A3 (en) | Inhibition of hiv-1 replication | |
| RU2000106709A (ru) | Пептиды-имитаторы консервативного эпитопа белка gp41 вируса иммунодефицита человека типа 1, узнаваемого вируснейтрализующими моноклональными антителами 2f5 | |
| JP2007515386A5 (cg-RX-API-DMAC7.html) | ||
| FR2652091B1 (fr) | Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in-vitro des infections dues a ces virus. | |
| DK0685235T3 (da) | Ekstrakter af Piliostigma thonningii, anvendelse heraf og formuleringer, som indeholder dem |